FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000414169> ?p ?o ?g. }

• W3000414169 endingPage "508" @default.
• W3000414169 startingPage "508" @default.
• W3000414169 abstract "Bergamottin (BM, 1), a component of grapefruit juice, acts as an inhibitor of some isoforms of the cytochrome P450 (CYP) enzyme, particularly CYP3A4. Herein, a new bergamottin containing a nitroxide moiety (SL-bergamottin, SL-BM, 10) was synthesized; chemically characterized, evaluated as a potential inhibitor of the CYP2C19, CYP3A4, and CYP2C9 enzymes; and compared to BM and known inhibitors such as ketoconazole (KET) (3A4), warfarin (WAR) (2C9), and ticlopidine (TIC) (2C19). The antitumor activity of the new SL-bergamottin was also investigated. Among the compounds studied, BM showed the strongest inhibition of the CYP2C9 and 2C19 enzymes. SL-BM is a more potent inhibitor of CYP3A4 than the parent compound; this finding was also supported by docking studies, suggesting that the binding positions of BM and SL-BM to the active site of CYP3A4 are very similar, but that SL-BM had a better ∆Gbind value than that of BM. The nitroxide moiety markedly increased the antitumor activity of BM toward HeLa cells and marginally increased its toxicity toward a normal cell line. In conclusion, modification of the geranyl sidechain of BM can result in new CYP3A4 enzyme inhibitors with strong antitumor effects." @default.
• W3000414169 created "2020-01-23" @default.
• W3000414169 creator A5005939076 @default.
• W3000414169 creator A5014395657 @default.
• W3000414169 creator A5028515389 @default.
• W3000414169 creator A5032633045 @default.
• W3000414169 creator A5035241451 @default.
• W3000414169 creator A5036667583 @default.
• W3000414169 creator A5047887299 @default.
• W3000414169 creator A5059140713 @default.
• W3000414169 creator A5067407522 @default.
• W3000414169 creator A5067828788 @default.
• W3000414169 creator A5090127565 @default.
• W3000414169 date "2020-01-13" @default.
• W3000414169 modified "2023-10-15" @default.
• W3000414169 title "Synthesis of Spin-Labelled Bergamottin: A Potent CYP3A4 Inhibitor with Antiproliferative Activity" @default.
• W3000414169 cites W1967630373 @default.
• W3000414169 cites W1972940640 @default.
• W3000414169 cites W1976709145 @default.
• W3000414169 cites W1985267421 @default.
• W3000414169 cites W1994301337 @default.
• W3000414169 cites W1997545624 @default.
• W3000414169 cites W1997982878 @default.
• W3000414169 cites W1999021046 @default.
• W3000414169 cites W2002463117 @default.
• W3000414169 cites W2011409674 @default.
• W3000414169 cites W2013822904 @default.
• W3000414169 cites W2022933008 @default.
• W3000414169 cites W2024964331 @default.
• W3000414169 cites W2028469287 @default.
• W3000414169 cites W2032084435 @default.
• W3000414169 cites W2034853089 @default.
• W3000414169 cites W2035019909 @default.
• W3000414169 cites W2049247931 @default.
• W3000414169 cites W2050244697 @default.
• W3000414169 cites W2055358851 @default.
• W3000414169 cites W2062111291 @default.
• W3000414169 cites W2062723451 @default.
• W3000414169 cites W2073970261 @default.
• W3000414169 cites W2079156486 @default.
• W3000414169 cites W2088466767 @default.
• W3000414169 cites W2092661856 @default.
• W3000414169 cites W2093925805 @default.
• W3000414169 cites W2105668062 @default.
• W3000414169 cites W2106050611 @default.
• W3000414169 cites W2110822024 @default.
• W3000414169 cites W2112542595 @default.
• W3000414169 cites W2114042463 @default.
• W3000414169 cites W2166827399 @default.
• W3000414169 cites W2167309323 @default.
• W3000414169 cites W2287306673 @default.
• W3000414169 cites W2400922885 @default.
• W3000414169 cites W2581247253 @default.
• W3000414169 cites W2618545929 @default.
• W3000414169 cites W2738325603 @default.
• W3000414169 cites W2799318687 @default.
• W3000414169 cites W2888229053 @default.
• W3000414169 cites W2904353725 @default.
• W3000414169 cites W2957457087 @default.
• W3000414169 cites W2982100807 @default.
• W3000414169 cites W3163647926 @default.
• W3000414169 cites W4299439956 @default.
• W3000414169 doi "https://doi.org/10.3390/ijms21020508" @default.
• W3000414169 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7013880" @default.
• W3000414169 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31941150" @default.
• W3000414169 hasPublicationYear "2020" @default.
• W3000414169 type Work @default.
• W3000414169 sameAs 3000414169 @default.
• W3000414169 citedByCount "14" @default.
• W3000414169 countsByYear W30004141692020 @default.
• W3000414169 countsByYear W30004141692021 @default.
• W3000414169 countsByYear W30004141692022 @default.
• W3000414169 countsByYear W30004141692023 @default.
• W3000414169 crossrefType "journal-article" @default.
• W3000414169 hasAuthorship W3000414169A5005939076 @default.
• W3000414169 hasAuthorship W3000414169A5014395657 @default.
• W3000414169 hasAuthorship W3000414169A5028515389 @default.
• W3000414169 hasAuthorship W3000414169A5032633045 @default.
• W3000414169 hasAuthorship W3000414169A5035241451 @default.
• W3000414169 hasAuthorship W3000414169A5036667583 @default.
• W3000414169 hasAuthorship W3000414169A5047887299 @default.
• W3000414169 hasAuthorship W3000414169A5059140713 @default.
• W3000414169 hasAuthorship W3000414169A5067407522 @default.
• W3000414169 hasAuthorship W3000414169A5067828788 @default.
• W3000414169 hasAuthorship W3000414169A5090127565 @default.
• W3000414169 hasBestOaLocation W30004141691 @default.
• W3000414169 hasConcept C109650736 @default.
• W3000414169 hasConcept C112705442 @default.
• W3000414169 hasConcept C159110408 @default.
• W3000414169 hasConcept C181199279 @default.
• W3000414169 hasConcept C185592680 @default.
• W3000414169 hasConcept C202751555 @default.
• W3000414169 hasConcept C2776773239 @default.
• W3000414169 hasConcept C2777366897 @default.
• W3000414169 hasConcept C2779548794 @default.
• W3000414169 hasConcept C2781064554 @default.
• W3000414169 hasConcept C41685203 @default.
• W3000414169 hasConcept C526171541 @default.

• next